2020
DOI: 10.1016/j.fertnstert.2020.01.022
|View full text |Cite
|
Sign up to set email alerts
|

Should we consider alternative therapies to operative hysteroscopy for the treatment of Asherman syndrome?

Abstract: Disclaimer: Authors for ''fertile battles'' are chosen to represent the full breadth of opinions. Individual authors, even within one side of the debate, do not necessarily agree with all viewpoints expressed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 80 publications
(79 reference statements)
0
6
0
Order By: Relevance
“…In 2020, a review gathered the controversial views of different researchers on the treatment of IUA [ 64 ]. One perspective advocated that the adjuvant treatment after the surgery should be given more attention, and another suggested that IUA be treated with multiple operations.…”
Section: Discussionmentioning
confidence: 99%
“…In 2020, a review gathered the controversial views of different researchers on the treatment of IUA [ 64 ]. One perspective advocated that the adjuvant treatment after the surgery should be given more attention, and another suggested that IUA be treated with multiple operations.…”
Section: Discussionmentioning
confidence: 99%
“…In cases of AS, the common clinical management is directed towards hysteroscopic removal of intrauterine adhesions, prevention of their recurrence, and reformation [28][29][30]. While adhesiolysis may appear as a sound management strategy, the treatment often fails particularly in subjects with severe intrauterine adhesions and significant clinical presentation such as amenorrhea [29].…”
Section: Asherman's Syndromementioning
confidence: 99%
“…The main treatment strategy for the mentioned endometrial dysfunction consists of medical therapy (estrogen therapy, vitamin E, pentoxifylline, L-arginine, aspirin, tamoxifen, sildenafil), surgical procedures (dilatation and curettage, hysteroscopy), devices and materials of re-adhesion prevention (intrauterine device, uterine stent, Foley's catheter, adhesion barriers), autologous cellular therapy (intrauterine infusion of granulocyte colony stimulating factor or autologous platelet-rich plasma) and assisted reproductive technology (ART) procedures (AAGL Elevating Gynecologic Surgery, 2017;Ranisavljevic et al, 2019;Santamaria et al, 2020;Mouanness et al, 2021;Strug and Aghajanova, 2021). Although multiple approaches to treatment are available, the overall curative outcome is quite inconsistent.…”
Section: Introductionmentioning
confidence: 99%